Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F1T70
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,914
Award facts
- Contract value 100% obligated
- $52,913.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $52,913.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Cosentyx (secukinumab) 300mg dose-2pen/mL, a prescription medication used to treat autoimmune inflammatory conditions. This is a non-set-aside, competitively awarded contract with an ultimate completion date of January 9, 2026, to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor and subsidiary of Cencora, Inc., maintains a significant presence in federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a diverse range of pharmaceutical products across multiple therapeutic domains on a competitive basis. This delivery order exemplifies the company's role as a critical vendor in the federal military healthcare supply chain, fulfilling pharmaceutical needs for military treatment facilities and related defense medical operations.
Quick answers
Who was awarded contract SPE2DR26F1T70?
SPE2DR26F1T70 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F1T70 worth?
The government has obligated $52,914 on SPE2DR26F1T70.
Is contract SPE2DR26F1T70 an order under another contract?
Yes. SPE2DR26F1T70 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T70 competed?
The extent of competition for SPE2DR26F1T70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award